Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Knispel

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Urology|March 27, 2007
Antibodies against botulinum neurotoxin type A as a cause of treatment failure after the first detrusor injectionHeinrich Schulte-Baukloh, Hans Bigalke, Gert Heine, et al.
Journal of Pediatric Urology|September 13, 2011
Urodynamic effects of propiverine in children and adolescents with neurogenic bladder: results of a prospective long-term studyHeinrich Schulte-Baukloh, Gerd Mürtz, Gert Heine, et al.
European Urology|June 30, 2009
Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre studyAndreas Böhle, Herbert Leyh, Christian Frei, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Urology|March 27, 2007
Antibodies against botulinum neurotoxin type A as a cause of treatment failure after the first detrusor injectionHeinrich Schulte-Baukloh, Hans Bigalke, Gert Heine, et al.
Journal of Pediatric Urology|September 13, 2011
Urodynamic effects of propiverine in children and adolescents with neurogenic bladder: results of a prospective long-term studyHeinrich Schulte-Baukloh, Gerd Mürtz, Gert Heine, et al.
European Urology|June 30, 2009
Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre studyAndreas Böhle, Herbert Leyh, Christian Frei, et al.
Pageof 6